Literature DB >> 23689556

Role of staphylococcal superantigens in airway disease.

Wouter Huvenne1, Peter W Hellings, Claus Bachert.   

Abstract

Staphylococcus aureus is a common human pathogen, which is regularly part of the normal microflora found in the nose and skin. It represents a significant threat to human health, not in the least because of its capability to produce exotoxins, which have superantigenic properties. These exotoxins, in particular the staphylococcal enterotoxins (SEs), are known to be involved in the modulation and aggravation of airway inflammation. Indeed, recent studies show an important impact of SEs on the natural course of allergic rhinitis, nasal polyposis, asthma and COPD. This review outlines the current knowledge on the influence of SEs on airway inflammation. We highlight, in particular, the recent evidence on their role in asthma.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23689556     DOI: 10.1159/000350329

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  24 in total

1.  CD80/CD86 signaling contributes to the proinflammatory response of Staphylococcus aureus in the airway.

Authors:  Dane Parker
Journal:  Cytokine       Date:  2018-07       Impact factor: 3.861

2.  Filaggrin mutations increase allergic airway disease in childhood and adolescence through interactions with eczema and aeroallergen sensitization.

Authors:  Adrian Chan; William Terry; Hongmei Zhang; Wilfried Karmaus; Susan Ewart; John W Holloway; Graham Roberts; Ramesh Kurukulaaratchy; Syed Hasan Arshad
Journal:  Clin Exp Allergy       Date:  2018-02       Impact factor: 5.018

Review 3.  Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis.

Authors:  Anna G Staudacher; Anju T Peters; Atsushi Kato; Whitney W Stevens
Journal:  Ann Allergy Asthma Immunol       Date:  2020-01-30       Impact factor: 6.347

Review 4.  Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis.

Authors:  Whitney W Stevens; Robert P Schleimer
Journal:  Immunol Allergy Clin North Am       Date:  2016-09-13       Impact factor: 3.479

Review 5.  Interaction of host and Staphylococcus aureus protease-system regulates virulence and pathogenicity.

Authors:  Vigyasa Singh; Ujjal Jyoti Phukan
Journal:  Med Microbiol Immunol       Date:  2018-11-27       Impact factor: 3.402

6.  TNF and CD28 Signaling Play Unique but Complementary Roles in the Systemic Recruitment of Innate Immune Cells after Staphylococcus aureus Enterotoxin A Inhalation.

Authors:  Julia Svedova; Naomi Tsurutani; Wenhai Liu; Kamal M Khanna; Anthony T Vella
Journal:  J Immunol       Date:  2016-04-20       Impact factor: 5.422

7.  Colonization of CF patients' upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa.

Authors:  Wibke Katharina Janhsen; Christin Arnold; Julia Hentschel; Thomas Lehmann; Wolfgang Pfister; Michael Baier; Klas Böer; Kerstin Hünniger; Oliver Kurzai; Uta-Christina Hipler; Jochen Georg Mainz
Journal:  Med Microbiol Immunol       Date:  2016-07-04       Impact factor: 3.402

Review 8.  Biologics for the Treatment of Allergic Rhinitis, Chronic Rhinosinusitis, and Nasal Polyposis.

Authors:  William Eschenbacher; Matthew Straesser; Alice Knoeddler; Rung-Chi Li; Larry Borish
Journal:  Immunol Allergy Clin North Am       Date:  2020-09-09       Impact factor: 3.479

9.  Staphylococcus aureus Induces a Mucosal Type 2 Immune Response via Epithelial Cell-derived Cytokines.

Authors:  Feng Lan; Nan Zhang; Gabriele Holtappels; Natalie De Ruyck; Olga Krysko; Koen Van Crombruggen; Harald Braun; Sebastian L Johnston; Nikos G Papadopoulos; Luo Zhang; Claus Bachert
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

10.  Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip.

Authors:  Christian Lupinek; Eva Wollmann; Alexandra Baar; Srinita Banerjee; Heimo Breiteneder; Barbara M Broecker; Merima Bublin; Mirela Curin; Sabine Flicker; Tetiana Garmatiuk; Heidrun Hochwallner; Irene Mittermann; Sandra Pahr; Yvonne Resch; Kenneth H Roux; Bharani Srinivasan; Sebastian Stentzel; Susanne Vrtala; Leanna N Willison; Magnus Wickman; Karin C Lødrup-Carlsen; Josep Maria Antó; Jean Bousquet; Claus Bachert; Daniel Ebner; Thomas Schlederer; Christian Harwanegg; Rudolf Valenta
Journal:  Methods       Date:  2013-10-22       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.